The pharmaceutical sector is at the dual bottom, and the medical innovation ETF (516820) rises more than 1%

Yesterday, the pharmaceutical sector rose across the board. Medical innovation ETF (516820) continued to attack early. As of 9:40, the fund rose more than 1%, and the transaction volume continued to amplify. Since September 19, the emotions of the pharmaceutical sector have entered the freezing point. From the perspective of the transaction volume, the transaction volume of the medical index of the pharmaceutical index from September 19th to September 26th has been less than 40 billion yuan In addition, the pharmaceutical sector is currently at the bottom of the valuation, and the plate is at the dual bottom of emotion+valuation.

There are two catalysts at the recent policy level:

1. Equipment discount loan policy. Relevant departments issued relevant suggestions and reference materials for purchase equipment in September. Wait for the expected goal and list the detailed equipment list. After the fiscal discount, the interest of the medical institution was below 0.7%.

2. On September 27, the National Organization of High -value Medical Consumption Office officially announced that the national organizational orthopedic spine consumables were selected. The orthopedic spine is divided into 14 product system categories, 29 bidding units, and 872 systems. The average price reduction is 84%, which is in line with market expectations.

In addition, the relaxation of the public health prevention and control policy in Hong Kong has also triggered the relaxation of domestic domestic prevention and control policies. The pharmaceutical sector that benefits from consultation and consumption recovery may also be favored by game funds.

Guojin Securities believes that after the nationwide orthopedic spine products are procurement, it is expected that manufacturers are expected to maintain reasonable profit margins, but the concentration of the industry will further increase. And use behavior to improve the industry ecology.

- END -